| |
Malcolm Gardner, Ph.D.
|
Education |
|
|
| Ph.D. |
Biochemistry |
Sept. 1980-Nov. 1985 |
University of Tennessee - Oak Ridge
Graduate School of Biomedical Sciences, Biology Division, Oak Ridge
National Laboratory, Oak Ridge, TN |
| B.S. |
Honors in Biology |
1980 |
Dickinson College, Carlisle,
PA |
| 2005 – Present |
Full Member, Seattle Biomedical Research Institute |
| 2003-2005 |
Investigator, Parasite Genomics Group,
The Institute for Genomic Research, Rockville, MD |
| 1999-2003 |
Associate Investigator, Parasite Genomics
Group, The Institute for Genomics Research, Rockville, MD |
| 1997-1999 |
Assistant Investigator, Department of
Eukaryotic Genomics, The Institute for Genomic Research, Rockville, MD |
| 1995 - 1997 |
Research Assistant Professor, Department
of Microbiology and Immunology, University of Maryland at Baltimore,
Baltimore, MD |
| 1993-1997 |
Senior Molecular Biologist, Malaria
Program, Naval Medical Research Institute, Rockville, MD |
| 1991-1993 |
National Research Council Senior Fellow,
Division of Experimental Therapeutics, Walter Reed Army Institute of
Research, Washington, DC |
| 1985-1991 |
Postdoctoral Fellow, Division of
Parasitology, National Institute for Medical Research, London, England |
Select Honors and Awards
1997-1996
Letters of Commendation (2), Naval Medical
Research Institute
1991
National Research Council Senior Fellow
1981
National Research Service Award
Field of Study
I entered the malaria field as a postdoc at
the National Institute for Medical Research in
London, drawn by the realization that malaria
was a tremendously important but relatively
under-studied disease. I thought that
there was a great deal yet to be learned about
the parasite at the molecular level. I
subsequently had a "once-in-a-lifetime"
opportunity to participate in the Plasmodium
falciparum genome project while working at
The Institute for Genome Research. The
genome sequence that was determined with our
partners at the Wellcome Trust Sanger Institute,
Stanford University, and the Naval Medical
Research Center is being used by scientist
worldwide to accelerate malaria research and to
identify new drug and vaccine targets.
At SBRI, I will extend my previous work in
genomics via laboratory investigations to learn
more about the biological roles of the
apicoplast, an essential parasite organelle that
contains novel drug targets but whose functions
in the malaria parasite have not been fully
characterized. I will also continue to
work on the improvement of the P. falciparum
genome annotation, and to collaborate with
others at SBRI and elsewhere to identify novel
vaccine antigens and drug targets. I also
welcome the opportunity to mentor the next
generation of malaria researchers.
|
|
back